Prostate cancer is the most common cancer in New Zealand men, with around 4,000 diagnoses annually. Māori and Pacific men are diagnosed at younger ages and often with more advanced disease. This guide covers the key funding sources for prostate cancer services, research, and support.
Prostate Cancer Foundation NZ (PCFNZ):
- Research grants: Prostate cancer science and clinical research
- Support groups: Patient and carer support groups nationwide
- Awareness: PSA awareness and prostate health information
- Navigator programme: Patient navigation through treatment decisions
Cancer Society NZ funds prostate cancer:
- Patient support: Information, support groups, and peer support
- Research grants: Prostate cancer research contribution
- Community education: Cancer awareness and prevention
Health system prostate cancer:
- PSA testing: GP-level PSA screening
- Urology services: Prostate biopsy, TRUS, and pathology
- Radiation oncology: External beam radiation and brachytherapy
- Surgical oncology: Radical prostatectomy (robotic and open)
- Systemic therapy: Hormone therapy and chemotherapy for advanced prostate cancer
HRC funds prostate cancer research:
- Clinical trials
- Epidemiology and prevention
- Translational research
Gaming trusts fund prostate cancer community programmes:
- Four Winds Foundation: Community health programmes
- Grassroots Trust: Community health
- Pub Charity: Men's health community events
- Lion Foundation: Community health
Gaming trust prostate cancer applications:
- Support group meetings and events
- PSA awareness campaigns for men over 50
- Patient navigation resources
- Transport to treatment
Equity in prostate cancer:
- Te Puni Kōkiri: Māori men's cancer health
- Ministry for Pacific Peoples: Pacific men's cancer
- Hauora Māori providers: Māori health providers supporting prostate cancer
Māori men are diagnosed with more advanced prostate cancer — earlier detection is a funding priority.
Active surveillance (monitoring low-risk prostate cancer without immediate treatment):
- Urology services: DHB-funded active surveillance protocols
- PSA testing: Ongoing monitoring
- Patient support: Anxiety management during active surveillance
Peer support for prostate cancer:
- PCFNZ: National support group network
- Cancer Society: Local support connections
- Gaming trusts: Support group event costs
Priority prostate cancer research:
- Early detection: Better PSA testing and MRI-guided biopsy
- Genomics: Genetic risk factors for prostate cancer
- Active surveillance: Optimal monitoring strategies
- Advanced prostate cancer: New treatments for castration-resistant disease
- Quality of life: Urinary and sexual outcomes after treatment
Strong applications demonstrate:
- Men reached: Number of men engaged with PSA awareness or support
- Equity: Māori and Pacific men's specific outreach
- Support outcomes: Reduced anxiety, better coping, informed treatment decisions
- Research: Scientific quality and clinical impact
- Clinical pathway: Integration with DHB urology services
- Carer support: Partners and family wellbeing
- Patient navigation: Men supported through complex treatment decisions
Tahua's grants management platform helps prostate cancer organisations manage grant applications across PCFNZ, Cancer Society NZ, gaming trusts, and health foundations, tracking awareness, support group participation, and research outcomes.